Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System

80Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tripterygium wilfordii Hook.f. (TWHF) has a long history as a Traditional Chinese Medicine (TCM) herb that aids in treating inflammatory and autoimmune diseases. The major bioactive component of TWHF is triptolide, which has been recognized to possess a broad spectrum of biological profiles including antiinflammatory, immunosuppressive, antifertility, and antitumor activities, as well as neurotrophic and neuroprotective effects. Limitation of triptolide, such as poor water solubility and severe systemic toxicity, has postponed clinical development and trials; however, the wide range of medicinal value of triptolide has been drawing intensive worldwide attention. In particular, triptolide has been shown to have significant effects on central nervous system (CNS) diseases, such as Parkinson's disease, Alzheimer's disease, spinal cord and brain injury, and multiple sclerosis. This review focuses on the potential therapeutic role of triptolide on CNS diseases, and discusses the structural features, potential modifications, and the other pharmacological activities of triptolide. © 2012 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Zheng, Y., Zhang, W. J., & Wang, X. M. (2013, February). Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System. CNS Neuroscience and Therapeutics. https://doi.org/10.1111/cns.12039

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free